サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臓器移植診断市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年、構成要素別、移植タイプ別、技術別、用途別、エンドユーザー別、企業別、地域別セグメント
市場調査レポート
商品コード
1289654

臓器移植診断市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年、構成要素別、移植タイプ別、技術別、用途別、エンドユーザー別、企業別、地域別セグメント

Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Transplant Type, By Technology, By Application, By End User, By company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 111 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

臓器移植診断市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年、構成要素別、移植タイプ別、技術別、用途別、エンドユーザー別、企業別、地域別セグメント
出版日: 2023年06月01日
発行: TechSci Research
ページ情報: 英文 111 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

臓器移植診断の世界市場は、予測期間2023-2027年に目覚ましい成長を遂げると予測されています。

主な要因としては、慢性疾患の蔓延、臓器移植手術件数の増加、移植診断分野における先端技術の採用などが挙げられ、これらは市場の成長を後押ししています。臓器移植とは、損傷または欠損した臓器の代用として、ある身体から臓器を取り出し、レシピエントの身体に装着する医療技術です。その他の市場成長要因としては、認知度向上のための政府の取り組み、高齢者人口の増加、臓器不全の発生率の増加、分子診断テストの高い需要、ヘルスケアと診断への投資と支出の急増、臓器移植手術の数の増加、臓器移植診断のプログラムおよび新製品開発の増加、および研究開発の増加、が挙げられます。

慢性疾患の増加

糖尿病や心血管疾患などの慢性疾患の発生が世界中で増加していることが、市場の成長を後押ししています。これは、慢性疾患を患う患者の臓器不全のリスクが高まることに起因しています。WHOによると、心血管疾患（CVD）は世界の主要な死因であり、毎年約1790万人の命を奪っています。また、老年人口は、特に肝臓、心臓、腎臓などの臓器不全に陥りやすいため、市場の成長を牽引しています。米国政府の臓器提供・移植に関する情報によると、2019年には、臓器移植を受けた人の63％が50歳以上であり、臓器移植者全体の21％が65歳以上です。

臓器移植の認知度向上と手術件数の増加

ここ数年、臓器移植に対する人々の意識が高まっており、それが市場の成長を後押ししています。臓器移植に対する人々の意識が高まり、臓器移植手術が行われるようになり、市場の成長に拍車をかけています。政府や非政府組織は、人々に臓器移植を認識させるために、さまざまな取り組みを行っています。さらに、臓器移植手術の件数が増加していることも、市場の成長を後押ししています。臓器不全の患者数の増加により、移植手術の需要が高まり、市場の成長を促進しています。Health Resources and Services Administrationによると、2019年には米国で約112,568人が臓器移植を必要としています。

利用可能なカスタマイズ

与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。レポートでは、以下のカスタマイズオプションが利用できます：

企業情報

  • 追加市場プレイヤー（最大5社）の詳細な分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 臓器移植診断の世界市場に対するCOVID-19の影響

第5章 顧客の声

第6章 臓器移植診断の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別（キット＆アッセイ、消耗品、サービス）
    • 移植タイプ別（固形臓器移植／幹細胞移植）
    • 技術別（分子技術、血清学、フローサイトメトリー、その他）
    • 用途別（臨床診断／トランスレーショナルリサーチ）
    • エンドユーザー別（病院・移植センター、学術・研究機関、その他）
    • 企業別（2021年）
    • 地域別
  • 市場マップ

第7章 北米の臓器移植診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 成分別
    • 臓器移植タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米の場合国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の臓器移植診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 成分別
    • 臓器移植タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域の臓器移植診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 成分別
    • 臓器移植タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域の国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の臓器移植診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 成分別
    • 臓器移植タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米の国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの臓器移植診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 成分別
    • 臓器移植の種類別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE
    • トルコ
    • エジプト

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開拓

第14章 競合情勢

  • Illumina, Inc.
  • Thermo Fischer Scientific, Inc.
  • Abbott Laboratories, Inc.
  • Quest Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Laboratory Corporation of America Holdings
  • bioMerieux S.A.
  • CareDx, Inc
  • Immucor, Inc.

第15章 戦略的提言

目次
Product Code: 13069

The global organ transplant diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing prevalence of chronic diseases, the increase in the number of organ transplantation surgeries, and the adoption of advanced technology in the field of transplant diagnostics, which are impelling the growth of the market. Organ transplantation is a medical technique in which an organ is removed from one body and placed in a recipient's body to substitute a damaged or missing organ. The other factors supporting the market's growth are, increasing government initiatives for spreading awareness, the rising geriatric population, the rising incidence of organ failure, high demand for molecular diagnostic tests, the surging investment and expenditure in healthcare and diagnostics, growing number of the organ transplant procedure, growing launch of programs & new product development in organ transplant diagnosis, and rise in research and development activities.

Rising Incidences of Chronic diseases

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe, are bolstering the growth of the market. This is attributed to the increased risk of organ failure among patients suffering from chronic diseases. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Also, the geriatric population is more prone to organ malfunction, especially the liver, heart, and kidney, thus, in turn, driving the growth of the market. As per the United States Government Information on Organ Donation and Transplantation, in 2019, 63 % of those who had organ transplants were aged 50 or older, and 21% of overall organ transplant individuals were aged 65 and above.

Increasing Awareness and Increase in the Number of Organ Transplantation Surgeries

Over the past few years, people are becoming more aware of organ transplantation, which is augmenting the growth of the market. Owing to the awareness among the masses, people are going for organ transplantation surgeries, which is fueling the growth of the market. Various initiatives are taken by the government and non-government organizations to make people aware of organ transplantation. Moreover, the rise in number of organ transplantation surgeries is fueling the growth of the market. Owing to the increase in the number of patients with organ failure, the demand for transplant procedures is rising, which is facilitating the growth of the market. According to Health Resources and Services Administration, in 2019, about 112,568 people in the U.S. required organ transplantation.

Market Segmentation

The global organ transplant diagnostics market is segmented into component, transplant type, technology, application, end-user, and company. Based on components, the market is divided into kits & assays, consumables, and services. Based on transplant type, the market is divided into solid organ transplants and stem cell transplants. Based on technology, the market is segmented into molecular technologies, serology, flow cytometry, and others. Based on application, the market is divided into clinical diagnostics and translational research. Based on end-user, the market is divided into hospitals & transplant centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the number of organ transplantation surgeries in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMerieux S.A., CareDx, Inc, and Immucor, Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global organ transplant diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Diagnostics Market, By Component:

  • Kits & Assays
  • Consumables
  • Services

Organ Transplant Diagnostics Market, By Transplant Type:

  • Solid Organ Transplant
  • Stem Cell Transplant

Organ Transplant Diagnostics Market, By Technology:

  • Molecular Technologies
  • Serology
  • Flow Cytometry
  • Others

Organ Transplant Diagnostics Market, By Application:

  • Clinical Diagnostics
  • Translational Research

Organ Transplant Diagnostics Market, By End User:

  • Hospitals & Transplant Centers
  • Academic & Research Institutions
  • Others

Organ Transplant Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Organ Transplant Diagnostics Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Organ Transplant Diagnostics Market

5. Voice of Customer

6. Global Organ Transplant Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Kits & Assays, Consumables, Services)
    • 6.2.2. By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant)
    • 6.2.3. By Technology (Molecular Technologies, Serology, Flow Cytometry, Others)
    • 6.2.4. By Application (Clinical Diagnostics v/s Translational Research)
    • 6.2.5. By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Market Map

7. North America Organ Transplant Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Transplant Type
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Organ Transplant Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Transplant Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Organ Transplant Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Transplant Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Organ Transplant Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Transplant Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Organ Transplant Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Transplant Type
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Organ Transplant Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Transplant Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Organ Transplant Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Transplant Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Organ Transplant Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Transplant Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Organ Transplant Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Transplant Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Organ Transplant Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Transplant Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Organ Transplant Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Transplant Type
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Organ Transplant Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Transplant Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Organ Transplant Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Transplant Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Organ Transplant Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Transplant Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Organ Transplant Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Transplant Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Organ Transplant Diagnostics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Transplant Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Organ Transplant Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Transplant Type
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Transplant Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Transplant Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Organ Transplant Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Transplant Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Organ Transplant Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Transplant Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Organ Transplant Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component
    • 11.2.2. By Transplant Type
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Organ Transplant Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Transplant Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Transplant Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Organ Transplant Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Transplant Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Organ Transplant Diagnostics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Transplant Type
        • 11.3.4.2.3. By Technology
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Egypt Organ Transplant Diagnostics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Transplant Type
        • 11.3.5.2.3. By Technology
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Illumina, Inc.
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Abbott Laboratories, Inc.
  • 14.4. Quest Diagnostics, Inc.
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Bio-Rad Laboratories, Inc.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. bioMerieux S.A.
  • 14.9. CareDx, Inc
  • 14.10. Immucor, Inc.

15. Strategic Recommendations